# US 2022/0044784 A1 · Configurable target values

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0044784 A1
- Document ID: US20220044784A1
- Status: Published application
- Kind: A1
- Application number: 17/505,867
- Filed: 2021-10-20
- Published: 2022-02-10
- Earliest claimed: 2016-12-21
- Assignees: Medtronic MiniMed, Inc.
- Applicants: Medtronic Minimed, Inc.
- Inventors: Benyamin Grosman; Anirban Roy; Neha J. Parikh; Louis J. Lintereur; Di Wu; Patrick E. Weydt
- Web page: https://patentgrep.com/patent/US20220044784A1

## CPC

- G16H 20/17: delivered via infusion or injection
- A61B 5/14532: {for measuring glucose, e.g. by tissue impedance measurement}
- A61B 5/4839: {combined with drug delivery}
- A61M 5/142: Pressure infusion, e.g. using pumps
- A61M 5/14244: {adapted to be carried by the patient, e.g. portable on the body}
- A61M 5/145: using pressurised reservoirs, e.g. by means of pistons
- A61M 5/16831: {Monitoring, detecting, signalling or eliminating infusion flow anomalies (low-level float-valves causing cut-off A61M5/40; indicating or recording presence, absence or direction of flow in general G01P13/0066)}
- A61M 5/1723: {using feedback of body parameters, e.g. blood sugar or pressure}
- G16H 10/20: for electronic clinical trials or questionnaires
- G16H 10/60: for patient-specific data, e.g. for electronic patient records
- G16H 20/60: relating to nutrition control, e.g. diets
- G16H 40/63: for local operation
- G16H 50/20: for computer-aided diagnosis, e.g. based on medical expert systems
- G16H 50/50: for simulation or modelling of medical disorders
- A61B 5/746: {Alarms related to a physiological condition, e.g. details of setting alarm thresholds or avoiding false alarms}
- A61B 5/7465: {Arrangements for interactive communication between patient and care services, e.g. by using a telephone network (telemetry of measured physiological signal A61B5/0002)}
- A61K 38/28: Insulins
- A61M 5/16804: {Active flow controllers}
- A61M 5/16877: {Passive flow controllers; Devices for setting a flow rate (clamp-type valves A61M39/28)}
- A61M 2005/14208: {with a programmable infusion control system, characterised by the infusion program}
- A61M 2205/18: with alarm
- A61M 2205/3303: Using a biosensor
- A61M 2205/35: Communication
- A61M 2205/3569: sublocal, e.g. between console and disposable
- A61M 2205/3584: using modem, internet or Bluetooth®
- A61M 2205/3592: using telemetric means, e.g. radio or optical transmission
- A61M 2205/50: with microprocessors or computers
- A61M 2205/502: User interfaces, e.g. screens or keyboards
- A61M 2205/52: with memories providing a history of measured variating parameters of apparatus or patient
- A61M 2205/8206: battery-operated
- A61M 2230/201: Glucose concentration
- A61M 2230/63: Motion, e.g. physical activity
- G16H 20/30: relating to physical therapies or activities, e.g. physiotherapy, acupressure or exercising
- G16H 50/30: for calculating health indices; for individual health risk assessment
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

Disclosed herein are techniques related to configurable target values. The techniques may involve identifying a target glucose value obtained based on user input. Additionally, the techniques may involve determining a fluid delivery command based on a difference between a measured glucose value and the target glucose value. The techniques may further involve causing fluid delivery by a fluid infusion device in accordance with the fluid delivery command to regulate the measured glucose value to the target glucose value.

## Claims

### Claim 1

A processor-implemented method comprising:
identifying a target glucose value obtained based on user input;
determining a fluid delivery command based on a difference between a measured glucose value and the target glucose value; and
causing fluid delivery by a fluid infusion device in accordance with the fluid delivery command to regulate the measured glucose value to the target glucose value.

### Claim 2 (depends on 1)

The method of claim 1, wherein causing fluid delivery comprises communicating the fluid delivery command to a motor assembly of the fluid infusion device.

### Claim 3 (depends on 1)

The method of claim 1, wherein the fluid delivery comprises a basal dosage delivery.

### Claim 4 (depends on 1)

The method of claim 1, wherein the fluid delivery comprises a bolus dosage delivery.

### Claim 5 (depends on 1)

The method of claim 1, wherein the target glucose value is obtained as user input at a computing device configured to communicate with the fluid infusion device.

### Claim 6 (depends on 1)

The method of claim 1, wherein the measured glucose value is obtained from a glucose sensing arrangement.

### Claim 7 (depends on 1)

The method of claim 1, wherein the target glucose value is automatically used when a probability of a meal being consumed with a prediction horizon is greater than a threshold value.

### Claim 8

A system comprising:
one or more processors; and
one or more processor-readable storage media storing instructions which, when executed by the one or more processors, cause performance of:
identifying a target glucose value obtained based on user input;
determining a fluid delivery command based on a difference between a measured glucose value and the target glucose value; and
causing fluid delivery by a fluid infusion device in accordance with the fluid delivery command to regulate the measured glucose value to the target glucose value.

### Claim 9 (depends on 8)

The system of claim 8, wherein causing fluid delivery comprises communicating the fluid delivery command to a motor assembly of the fluid infusion device.

### Claim 10 (depends on 8)

The system of claim 8, wherein the fluid delivery comprises a basal dosage delivery.

### Claim 11 (depends on 8)

The system of claim 8, wherein the fluid delivery comprises a bolus dosage delivery.

### Claim 12 (depends on 8)

The system of claim 8, wherein the target glucose value is obtained as user input at a computing device configured to communicate with the fluid infusion device.

### Claim 13 (depends on 8)

The system of claim 8, wherein the measured glucose value is obtained from a glucose sensing arrangement.

### Claim 14 (depends on 8)

The system of claim 8, wherein the target glucose value is automatically used when a probability of a meal being consumed with a prediction horizon is greater than a threshold value.

### Claim 15

One or more non-transitory processor-readable storage media storing instructions which, when executed by one or more processors, cause performance of:
identifying a target glucose value obtained based on user input;
determining a fluid delivery command based on a difference between a measured glucose value and the target glucose value; and
causing fluid delivery by a fluid infusion device in accordance with the fluid delivery command to regulate the measured glucose value to the target glucose value.

### Claim 16 (depends on 15)

The one or more non-transitory processor-readable storage media of claim 15, wherein causing fluid delivery comprises communicating the fluid delivery command to a motor assembly of the fluid infusion device.

### Claim 17 (depends on 15)

The one or more non-transitory processor-readable storage media of claim 15, wherein the fluid delivery comprises a basal dosage delivery.

### Claim 18 (depends on 15)

The one or more non-transitory processor-readable storage media of claim 15, wherein the fluid delivery comprises a bolus dosage delivery.

### Claim 19 (depends on 15)

The one or more non-transitory processor-readable storage media of claim 15, wherein the target glucose value is obtained as user input at a computing device configured to communicate with the fluid infusion device.

### Claim 20 (depends on 15)

The one or more non-transitory processor-readable storage media of claim 15, wherein the measured glucose value is obtained from a glucose sensing arrangement.